S448 - Amendments to Schedule VI of the Controlled Substances Act. (SL 2022-9)

Overview: S.L. 2022-9 automatically allows a prescription drug approved under federal law and classified as a Schedule VI controlled substance in North Carolina, to be lawfully used.

This act became effective July 14, 2022, and applies to prescription drugs approved by the FDA on or after that date.